biostudies-literatureUnknown17Guirgis L<h4>Background</h4>Pulmonary autograft reinforcement to prevent dilatation and subsequent neo-aortic valve regurgitation has been reported; however, data on long-term function of the neo-aortic valve after this modified Ross procedure are lacking. Our objective here was to assess long-term outcomes of the modified Ross procedure with autograft reinforcement using the reimplantation technique.<h4>Patients</h4>The outcomes of 61 consecutive patients managed using the Dacron-conduit reinforced Ross procedure between 2009 and 2021 were reviewed. Most patients had a unicuspid or bicuspid aortic valve (n = 52; 85%), predominant aortic valve regurgitation (n = 42; 77%), and >30 mm dilatation of the ascending aorta (n = 33; 54%). A prior aortic valve procedure was noted in 47 patients (77%) patienJTCVS techniques121-128https://www.ebi.ac.uk/biostudies/studies/S-EPMC9938391biostudies-literatureOutcomes after the Ross procedure with pulmonary autograft reinforcement by reimplantation.PMC9938391Guirgis LHascoet SBelli ERadojevic JCohen SVan Aerschot ILy MfalseOutcomes after the Ross procedure with pulmonary autograft reinforcement by reimplantation.<h4>Background</h4>Pulmonary autograft reinforcement to prevent dilatation and subsequent neo-aortic valve regurgitation has been reported; however, data on long-term function of the neo-aortic valve after this modified Ross procedure are lacking. Our objective here was to assess long-term outcomes of the modified Ross procedure with autograft reinforcement using the reimplantation technique.<h4>Patients</h4>The outcomes of 61 consecutive patients managed using the Dacron-conduit reinforced Ross procedure between 2009 and 2021 were reviewed. Most patients had a unicuspid or bicuspid aortic valve (n = 52; 85%), predominant aortic valve regurgitation (n = 42; 77%), and >30 mm dilatation of the ascending aorta (n = 33; 54%). A prior aortic valve procedure was noted in 47 patients (77%) patien2023-01-01T00:00:00Z2023 Feb2025-04-04T13:35:46.942Z2025-04-04T13:35:46.942ZS-EPMC99383913682034610.1016/j.xjtc.2022.11.016